Amarin Corp PLC (AMRN)
0.8812
-0.04
(-3.91%)
USD |
NASDAQ |
Apr 18, 16:00
0.88
0.00 (0.00%)
Pre-Market: 20:00
Amarin Profit Margin (Quarterly): -7.74% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -7.74% |
September 30, 2023 | -29.23% |
June 30, 2023 | -21.90% |
March 31, 2023 | -19.15% |
December 31, 2022 | 0.95% |
September 30, 2022 | -5.72% |
June 30, 2022 | -74.07% |
March 31, 2022 | -33.35% |
December 31, 2021 | 10.17% |
September 30, 2021 | -9.26% |
June 30, 2021 | 5.05% |
March 31, 2021 | -1.14% |
December 31, 2020 | 2.95% |
September 30, 2020 | -4.34% |
June 30, 2020 | 3.26% |
March 31, 2020 | -13.26% |
December 31, 2019 | 4.93% |
September 30, 2019 | -3.08% |
June 30, 2019 | -1.81% |
March 31, 2019 | -33.34% |
December 31, 2018 | -43.54% |
September 30, 2018 | -44.23% |
June 30, 2018 | -64.98% |
March 31, 2018 | -54.86% |
December 31, 2017 | -41.71% |
Date | Value |
---|---|
September 30, 2017 | -22.86% |
June 30, 2017 | -30.14% |
March 31, 2017 | -60.46% |
December 31, 2016 | -70.95% |
September 30, 2016 | -48.18% |
June 30, 2016 | -40.33% |
March 31, 2016 | -116.6% |
December 31, 2015 | -82.20% |
September 30, 2015 | -142.8% |
June 30, 2015 | -178.0% |
March 31, 2015 | -195.4% |
December 31, 2014 | -119.3% |
September 30, 2014 | -184.1% |
June 30, 2014 | |
March 31, 2014 | -236.9% |
December 31, 2013 | -152.5% |
September 30, 2013 | -581.7% |
June 30, 2013 | -723.2% |
March 31, 2013 | -2.66K% |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-74.07%
Minimum
Jun 2022
10.17%
Maximum
Dec 2021
-10.35%
Average
-4.34%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
Trinity Biotech PLC | -45.79% |
DBV Technologies SA | -- |
Adaptimmune Therapeutics PLC | -20.74K% |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -10.35% |
Return on Assets | -6.91% |
Return on Invested Capital | -10.35% |
Gross Profit Margin (Quarterly) | 60.40% |
Operating Margin (Quarterly) | -6.17% |
Return on Net Operating Assets | -14.89% |